what code are assigned for a patient admitted for chemotherapy for an azathioprione. I drug induced aplastic anemia? The patient has peripheral neuropathy of multiple joints of the lower extremities secondary to severe rheumatoid arthritis
Code(s) with the POA indicatior
To assign the appropriate codes for a patient admitted for chemotherapy for azathioprione-induced aplastic anemia, as well as peripheral neuropathy of multiple joints of the lower extremities secondary to severe rheumatoid arthritis, you need to follow the coding guidelines.
The first step is to determine the appropriate code for the principal diagnosis. In this case, it would be azathioprine-induced aplastic anemia. The ICD-10-CM code for this condition is D61.1 (Other drug-induced aplastic anemia).
Next, you need to identify the code(s) for the peripheral neuropathy. Since the peripheral neuropathy is due to severe rheumatoid arthritis, you would assign the appropriate code(s) for rheumatoid arthritis with peripheral neuropathy. The ICD-10-CM code for rheumatoid arthritis is M05 (Seropositive rheumatoid arthritis). However, there is not a specific code for peripheral neuropathy associated with rheumatoid arthritis. In this case, you would use an additional code to specify the peripheral neuropathy.
For the POA (Present on Admission) indicator, you would need to consult the medical record or clinical documentation to determine if the conditions were present at the time of admission. This information is important for accurate coding and documentation purposes.
To summarize, the codes for the scenario you provided would include:
- D61.1 - Other drug-induced aplastic anemia
- M05 - Rheumatoid arthritis
- Additional code for peripheral neuropathy associated with rheumatoid arthritis, if documented
Remember to review the official coding guidelines and consult with a qualified healthcare professional or coding specialist for specific coding advice and validation.